UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030714
Receipt number R000035065
Scientific Title Effect of acupuncture on major depressive disorder and bipolar disorder
Date of disclosure of the study information 2018/01/06
Last modified on 2021/11/04 11:41:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of acupuncture on major depressive disorder and bipolar disorder

Acronym

Effect of acupuncture on major depressive disorder and bipolar disorder

Scientific Title

Effect of acupuncture on major depressive disorder and bipolar disorder

Scientific Title:Acronym

Effect of acupuncture on major depressive disorder and bipolar disorder

Region

Japan


Condition

Condition

Major Depressive Disorder
Bipolar Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the effect of acupuncture treatment on depression and bipolar disorder.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Himorogi self-rating depression scale

Key secondary outcomes

Himorogi self-rating anxiety scale
Somatic Symptom Scale-8
Visual Analogue Scale
SF8 Health Survey
Salivary cortisol


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Acupuncture

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Those aged 18 or over with MDD(by DSM-5)
2.Those aged 18 or over with BD(by DSM-5)

Key exclusion criteria

1.Those with convulsive disorders such as schizoph.
2.Those with depression or depressive state caused by organic brain damages.
3.Those with severe disorders in liver, kidney, blood or circulation.
4.Those with malignancy or its previous history.
5.Those pregnant, nursing, or who may become pregnant.
6.Those with heavy suicidal tendency, previous history of suicidal ideation, or suicide attempt.
7.Those with personality disorder, mental retardation or intractable depression at a physician's discretion.
8.Those with substance dependence or drug abuse (excluding disorders related to nicotine).

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tomomi
Middle name
Last name Sakai

Organization

Tokyo Ariake University of Medical and Health Science

Division name

Department of Acupuncture and Moxibustion

Zip code

135-0063

Address

2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan

TEL

+08-3-6703-7014

Email

matsuuray@tau.ac.jp


Public contact

Name of contact person

1st name Yuto
Middle name
Last name Matsuura

Organization

Graduate School of Tokyo Ariake University of Medical and Health Sciences

Division name

Doctor's Program of Health Sciences

Zip code

135-0063

Address

2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan

TEL

+08-3-6703-7014

Homepage URL


Email

himorogi.hari@gmail.com


Sponsor or person

Institute

Tokyo Ariake University of Medical and Health Science

Institute

Department

Personal name



Funding Source

Organization

Tokyo Ariake University of Medical and Health Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Himorogi Psychiatric Institute

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Ariake University of Medical and Health Science

Address

2-9-1 Ariake Koto-ku, Tokyo 135-0063 Japan

Tel

+08-3-6703-7000

Email

akiyama@tau.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

市ヶ谷ひもろぎクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 01 Day

Date of IRB

2017 Year 04 Month 19 Day

Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 01 Month 06 Day

Last modified on

2021 Year 11 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035065


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name